Want to join the conversation?
$BLK's total expense declined 4% YoverY, helped by lower compensation expense. Employee compensation expense for 3Q16 fell 6% YoverY, helped by lower incentive compensation, driven by lower performance fees. For 4Q16, the company expects G&A expense to be moderately lower than a year ago's normalized levels.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?